Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials
- PMID: 15561731
- PMCID: PMC534841
- DOI: 10.1136/bmj.38273.626655.63
Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials
Abstract
Objective: To estimate the analgesic efficacy of non-steroidal anti-inflammatory drugs (NSAIDs), including selective cyclo-oxygenase-2 inhibitors (coxibs), in patients with osteoarthritis of the knee.
Design: Systematic review and meta-analysis of randomised placebo controlled trials.
Studies reviewed: 23 trials including 10 845 patients, median age of 62.5 years. 7807 patients received adequate doses of NSAIDs and 3038 received placebo. The mean weighted baseline pain score was 64.2 mm on 100 mm visual analogue scale (VAS), and average duration of symptoms was 8.2 years.
Main outcome measure: Change in overall intensity of pain.
Results: Methodological quality of trials was acceptable, but 13 trials excluded patients before randomisation if they did not respond to NSAIDs. One trial provided long term data for pain that showed no significant effect of NSAIDs compared with placebo at one to four years. The pooled difference for pain on visual analogue scale in all included trials was 10.1 mm (95% confidence interval 7.4 to 12.8) or 15.6% better than placebo after 2-13 weeks. The results were heterogeneous, and the effect size for pain reduction was 0.32 (0.24 to 0.39) in a random effects model. In 10 trials that did not exclude non-responders to NSAID treatment the results were homogeneous, with an effect size for pain reduction of 0.23 (0.15 to 0.31).
Conclusion: NSAIDs can reduce short term pain in osteoarthritis of the knee slightly better than placebo, but the current analysis does not support long term use of NSAIDs for this condition. As serious adverse effects are associated with oral NSAIDs, only limited use can be recommended.
Figures
Comment in
-
Managing osteoarthritis of the knee: conclusions about use of NSAIDs are misleading.BMJ. 2005 Mar 19;330(7492):672; author reply 672-3. doi: 10.1136/bmj.330.7492.672-b. BMJ. 2005. PMID: 15775007 Free PMC article. No abstract available.
References
-
- Andrianakos A, Trontzas P, Christoyannis F, Dantis P, Voudouris C, Georgountzos A, et al. Prevalence of rheumatic diseases in Greece: a cross-sectional population based epidemiological study. The ESORDIG study. J Rheumatol 2003;30: 1589-601. - PubMed
-
- Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 2000;133: 635-46. - PubMed
-
- Vaatainen U, Lohmander LS, Thonar E, Hongisto T, Agren U, Ronkko S, et al. Markers of cartilage and synovial metabolism in joint fluid and serum of patients with chondromalacia of the patella. Osteoarthr Cartil 1998;6: 115-24. - PubMed
-
- Suenaga S, Abeyama K, Indo H, Shigeta K, Noikura T. Temporomandibular disorders: MR assessment of inflammatory changes in the posterior disk attachment during the menstrual cycle. J Comput Assist Tomogr 2001;25: 476-81. - PubMed
-
- Speldewinde GC, Bashford GM, Davidson IR. Diagnostic cervical zygapophyseal joint blocks for chronic cervical pain. Med J Aust 2001;174: 174-6. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials